KYOTO, Japan– Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) announced today that has successfully commercialized and mass produced “CELLNETTA,” the world’s firstmetal cell fractionation filter designed for the rapid and precise selection and recovery of target cells from cell suspensions used in regenerative medicine and cell pharmaceutical research and development. Target applications include fractionation (selection and recovery), concentration, and filtration in research and development for regenerative medicine technologies or cellular pharmaceuticals, as well as biotechnology across agriculture, forestry, food, and energy industries. The product will be showcased at the 24th Annual Meeting of the Japanese Society for Regenerative Medicine happening March 20-22, 2025 at Pacifico Yokohama North.
